Zacks Investment Research lowered shares of Select Medical (NYSE:SEM) from a hold rating to a sell rating in a research report sent to investors on Saturday morning.

According to Zacks, “Select Medical Holdings Corporation, through its subsidiaries, operates specialty hospitals and outpatient rehabilitation clinics. The company’s Specialty Hospital segment offers long-term acute care hospital services and inpatient acute rehabilitative hospital care services. Its Outpatient Rehabilitation segment operates clinics and provides physical, occupational, and speech rehabilitation services. The company also provides medical rehabilitation services on a contract basis to nursing homes, hospitals, assisted living and senior care centers, schools, and work sites. The Mission of Select Medical Corporation is to ensure high-quality health care and cost-effective outcomes by providing specialty inpatient long-term acute care and rehabilitation, and outpatient rehabilitation services. The company is headquartered in Mechanicsburg, Pennsylvania. “

A number of other brokerages also recently issued reports on SEM. Deutsche Bank reaffirmed a buy rating and issued a $22.00 target price on shares of Select Medical in a research note on Monday, November 6th. Wells Fargo & Co reaffirmed an outperform rating and issued a $26.00 target price on shares of Select Medical in a research note on Tuesday, January 30th. ValuEngine raised Select Medical from a hold rating to a buy rating in a research note on Sunday, December 31st. Robert W. Baird reaffirmed a buy rating and issued a $21.00 target price on shares of Select Medical in a research note on Tuesday, October 17th. Finally, Bank of America raised Select Medical from an underperform rating to a neutral rating and set a $19.00 target price for the company in a research note on Thursday, January 4th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company. The stock presently has a consensus rating of Hold and an average price target of $20.25.

Shares of Select Medical (NYSE:SEM) opened at $16.95 on Friday. Select Medical has a 52 week low of $12.00 and a 52 week high of $19.77. The stock has a market capitalization of $2,335.24, a price-to-earnings ratio of 23.22, a price-to-earnings-growth ratio of 1.10 and a beta of 1.30. The company has a quick ratio of 1.51, a current ratio of 1.51 and a debt-to-equity ratio of 3.36.

In related news, insider Martin F. Jackson sold 134,029 shares of the firm’s stock in a transaction dated Friday, December 22nd. The stock was sold at an average price of $17.05, for a total transaction of $2,285,194.45. Following the completion of the sale, the insider now directly owns 1,717,944 shares of the company’s stock, valued at approximately $29,290,945.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Scott A. Romberger sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $17.97, for a total value of $89,850.00. Following the sale, the insider now directly owns 168,211 shares of the company’s stock, valued at $3,022,751.67. The disclosure for this sale can be found here. Insiders have sold a total of 295,955 shares of company stock valued at $5,052,199 over the last three months. Corporate insiders own 19.93% of the company’s stock.

Large investors have recently modified their holdings of the stock. PNC Financial Services Group Inc. increased its position in shares of Select Medical by 4.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 8,709 shares of the health services provider’s stock worth $133,000 after purchasing an additional 396 shares during the last quarter. Flinton Capital Management LLC grew its position in Select Medical by 75.8% in the 2nd quarter. Flinton Capital Management LLC now owns 9,744 shares of the health services provider’s stock valued at $150,000 after acquiring an additional 4,200 shares in the last quarter. Shelton Capital Management acquired a new position in Select Medical in the 2nd quarter valued at about $164,000. Eqis Capital Management Inc. acquired a new position in Select Medical in the 3rd quarter valued at about $201,000. Finally, Amalgamated Bank grew its position in Select Medical by 2.6% in the 2nd quarter. Amalgamated Bank now owns 14,806 shares of the health services provider’s stock valued at $227,000 after acquiring an additional 376 shares in the last quarter. 77.87% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Select Medical (SEM) Rating Lowered to Sell at Zacks Investment Research” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at https://www.dailypolitical.com/2018/02/06/select-medical-sem-rating-lowered-to-sell-at-zacks-investment-research.html.

Select Medical Company Profile

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Get a free copy of the Zacks research report on Select Medical (SEM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.